abstract |
The present invention relates to novel uses of ARH1 protein or a gene encoding the same, more particularly, to an NF-?B inhibitor comprising the ARH1 protein or the gene encoding the same as an active ingredient and a composition for the treatment of angiogenesis-related diseases, inflammatory diseases, autoimmune diseases, or viral diseases, comprising the inhibitor. |